NovaBay

NovaBay Pharmaceuticals is a biopharmaceutical company that is commercializing and developing non-antibiotic anti-infective products that address unmet therapeutic needs of the global topical anti-infective market. The Company has two distinct product categories: the NEUTROX? family of products, including the commercial prescription products Avenova? Daily Lid & Lash Hygiene and NeutroPhase? Skin and Wound Cleanser, and its Aganocide? compounds. NovaBay is gaining traction in the U.S. market with Avenova for the management of the chronic eye lid conditions. The Company has a pipeline of innovate eye care products and recently introduced the intelli-Case, an FDA-cleared high-tech, easy-to-use device for use with hydrogen peroxide disinfection solutions with soft and rigid gas permeable contact lenses. NovaBay has a highly experienced management team under the leadership of founder and CEO Ramin (Ron) Najafi. Mission:?NovaBay Pharmaceuticals is a biopharmaceutical company that is commercializing and developing non-antibiotic anti-infective products that address unmet therapeutic needs of the global topical anti-infective market.